Kolmar Korea Co Ltd
KRX:161890
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
43 500
76 200
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Kolmar Korea Co Ltd
Kolmar Korea Co Ltd
Cost of Revenue
Kolmar Korea Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Cost of Revenue
-₩1.7T
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-18%
|
|
|
AmorePacific Corp
KRX:090430
|
Cost of Revenue
-₩1.1T
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
|
Amorepacific Group
KRX:002790
|
Cost of Revenue
-₩1.2T
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
|
Cosmax Inc
KRX:192820
|
Cost of Revenue
-₩1.7T
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
LG H&H Co Ltd
KRX:051900
|
Cost of Revenue
-₩3.2T
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
|
H
|
Hyundai Bioscience Co Ltd
KOSDAQ:048410
|
Cost of Revenue
-₩4.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
24%
|
CAGR 10-Years
14%
|
|
Kolmar Korea Co Ltd
Glance View
Kolmar Korea Co., Ltd. engages in the original design manufacturing and original equipment manufacturing of cosmetics and pharmaceuticals. The company is headquartered in Sejong, Sejong. The company went IPO on 2012-10-19. The firm operates its business through three segments. The Cosmetics segment is mainly engaged in the business of original development and design manufacturing (ODM) and original equipment manufacturing (OEM) of cosmetics including skin care, makeup, hair care, body care and others. The Pharmaceutical segment develops and manufactures pharmaceuticals and quasi-drugs including ointment creams, oral solutions, external preparations, and solid preparations. The Food segment is involved in the production and sale of health functional food. The firm is also involved in the rental business. The firm distributes its products in domestic and overseas markets.
See Also
What is Kolmar Korea Co Ltd's Cost of Revenue?
Cost of Revenue
-1.7T
KRW
Based on the financial report for Sep 30, 2024, Kolmar Korea Co Ltd's Cost of Revenue amounts to -1.7T KRW.
What is Kolmar Korea Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-18%
Over the last year, the Cost of Revenue growth was -11%. The average annual Cost of Revenue growth rates for Kolmar Korea Co Ltd have been -17% over the past three years , -12% over the past five years , and -18% over the past ten years .
You don't have any saved screeners yet
